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Expression of the murine erythropoietin receptor (EpoR) gene was investigated in progenitor cell lines representing distinct stages of hematopoietic differentiation. In murine erythroid cell lines, the EpoR mRNA level was fivefold higher in the more mature murine erythroleukemia (MEL) cells than in CB-5 cells and very low in granulocyte/macrophage-like FDC-P1 cells. GATA-1 mRNA was present in equivalent levels in both erythroid cell lines, but at a low level in FDC-P1 cells. To account for the elevated levels of EpoR mRNA, the activity of the promoter and expression of DNase I hypersensitive sites were assessed as markers of transcriptional activity in various cell lines. Among a series of 5 flanking restriction fragments linked to a reporter gene, a 83-bp fragment that includes binding sites for the transcription factors GATA-1 and Sp-l gave low levels of erythroid-specific activity, and a 256-bp fragment that includes, in addition, two sites for the putative CACCC-binding protein gave the highest level of erythroid-specific transcription. DNase I footprinting showed binding of a constitutive factor to the proximal CACCC-binding site, and deletion or mutation of this site significantly reduced RYTHROPOIESIS IN MAMMALS progresses from multipotent hematopoietic cells to lineagecommitted erythroid progenitors. Multipotent cells grow in the presence of interleukin (IL) 3, granulocyte-macrophage colony-stimulating factor (GM-CSF). and Steel However, soon after committment to the erythroid lineage, erythropoietin (Epo) becomes the principal agent in regulating the survival of progenitor cells34 by its interaction with specific cetl-surface receptors (EpoR) on appropriate cell types? Within the fetal liver and adult bone marrow, the earliest erythroid progenitor cell is the slowly proliferating burst forming unit-erythroid (BFUe), which is weakly responsive to Epo. After additional 4 to 5 days in culture, the BFUe gives rise to the colony forming unit-erythroid (CFUe), which is highly responsive to Epo and generates erythroblast colonies within a few day^.^,^ Thus, the acquisition of Epo sensitivity marks an important physiological transition in erythropoiesis.
The sequential changes in cytokine requirement, morphology, and site of synthesis of mammalian erythroid progenitors predicts a mechanism for the temporal regulation Three DNase I hypersensitive sites were detected in the 5' flanking region of the EpoR gene, two of which were unique to MEL cells. These sites were situated over the promoter region and approximately 0.5 kb and 2.4 kb upstream of the transcriptional initiation sites. A 0.8-kb restriction fragment spanning the distal site caused approximately a fourfold rise in transcription from the endogenous or a heterologous promoter in MEL cells independent of its orientation and up to 1 .5-fold rise in CB-5 cells, but it was inactive in COS-l cells that were cotransfected with an expression plasmid encoding GATA-1. These results show that (1 ) basal activity as well as tissue specificity of the EpoR promoter can be accounted for by its interaction with GATA-1, and (2) upstream sites regulate the strength of the promoter. Expression of the distal DNase I hypersensitive site and the corresponding enhancer activity in MEL cells suggests a role for this element in stage-specific transcriptional control.
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of gene expression during erythropoiesis. The cloning of genomic for the murine EpoR has laid the groundwork for analysis of the genetic regulation of this receptor during early erythropoiesis. A 450-bp fragment has been shown previously to function as a promoter, which is critically dependent on the transcription factors Sp-l and GATA-1 for
The promoter is transactivated with coexpression of GATA-I in nonerythroid cells (NIH3T3 and COS), and mutagenesis ofthe GATA-l-binding site almost completely abolishes its activity.".'* However, the global regulation of the EpoR gene may be more complex in vivo, as shown by the presence of an inhibitory sequence upstream of the promoter which probably influences the basal activity of the promoter.13 Transcription of the EpoR gene ensues on differentiation of murine embryonic stem cells in vitro into erythroid p r e c~r s o r s ,~~ although the specific stage of erythropoiesis at which this event takes place is unknown. Later in differentiation, a number of studies have shown a change in surface expression of the EpoR, reaching a peak at the CFUe stage,15"' which correlates with the heightened sensitivity of these cells to Epo. This phase of activation may be attributable in part to stagespecific regulation of EpoR gene tran~cription.~ On further differentiation, transcription of the human EpoR gene appears to decline in a liquid culture system," attesting to the dynamic regulation of EpoR gene transcription during mammalian erythropoiesis. In this study, the mechanisms oftranscriptional activation ofthe EpoR gene were explored further by the characterization of accessory cis-acting sequences that regulate the function of the promoter. In vitro DNase I,fi,otprint analvsis. The footprinting procedure was similar to one described p r e v i~u s l y .~~ Two probes that span the 5' flanking region from -752 bp to -138 bp (the position designations are relative to the A of the initiation codon ATG [+l bp]) were prepared by the polymerase chain reaction (PCR). For each reaction, the primer corresponding to the antisense strand (relative to the downstream gene) was radiolabeled using T4 polynucleotide GATA-1. RNA ana/-vsis. Isolation of total RNA from tissue culture cells was performed as described.28 Forty-microgram aliquots of RNA were fractionated on 1% agarose gels containing 6% formaldehyde and transferred to nylon membranes (Biotrans) as described by the manufacturer. DNA fragments were labeled with [ c Y -~~P ]~C T P by random priming (Boehringer-Mannheim, Mannheim, Germany) to a specific activity of about IO9 cpm/mg. Filters were hybridized in a solution containing 50% formamide at 42°C and washed successively at 55°C for 1 hour and 60°C for 30 minutes in 0. I X SSC/ 0.1% SDS.
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Plasmid constructions. The human growth hormone (hGH) gene was used as a reporter as described p r e v i o~s l y .~~ Restriction fragments of the 5' flanking region of the murine EpoR gene were subcloned into the polylinker region of pOGH (which contains no eukaryotic promoter) or pTKGH (which contains the herpesvirus thymidine kinase [TK] promoter) upstream of the human hGH gene. To facilitate subcloning, both plasmids were modified by For personal use only. on October 3, 2017. by guest www.bloodjournal.org From 1430 obliterating the unique EcoRi site at the 3' end of the hGH gene. For experiments involving the demonstration of enhancer activity, a I .46-kb BamHI-Nael fragment from the 5' flanking region of the EpoR gene that contains the rodent repetitive element (RRE) was deleted from the constructs. The murine GATA-I cDNA cloned in the expression vector pXM (kind gift of Dr S.H. Orkin) was used in cotransfection assays.
Electroporation ofhematopoietic cells. Fifty micrograms of supercoiled plasmid DNA containing inserts from the murine EpoR gene and IO pg of plasmid pCH 1 10 DNA (Pharmacia, Piscataway, NJ) encoding the LacZ gene of Escherichia coli were incubated with -I X IO' MEL, CB-5 or FDC-P1 cells on ice for IO minutes, followed by electroporation (Bio-Rad, Richmond, CA) at 25 kV and 960 pF in 0.4-cm gap cuvettes, as described previously.8 The medium was assayed 72 hours after transfection for hGH activity using a radio-immunoassay procedure (Nichols institute, San Juan Capistrano, CA),29 and the cell pellet was subjected to histochemical staining for P-galacto~idase.~~ LacZ-positive cells were quantitated by visual inspection under a X 10 light microscope. In general, CB-5 cells were difficult to transfect successfully, as observed previo~sly.'~ COS-l cell transfection. Plasmid DNA was resuspended in 1.5 mL of DMEM-IO% newborn calf serum and a solution of diethyl aminoethyl-dextran and chloroquine, and transfection performed as described previously3' in 60-cm dishes on COS-l cells that were approximately 50% confluent. The concentrations ofplasmid DNA were 2 pg/mL (for hGH-containing plasmids) or 0.1 pg/mL (for pCHl I O or GATA-1 cloned in pXM) of transfection medium. Forty-eight hours after transfection, the supernatant was clarified by centrifugation and the amount of hGH measured as described above. An aliquot of the trypsinized cell pellet was used for P-galactosidase histochemical staining and quantitated by light micros-COPY.
RESULTS
Expression of the EpoR and GATA-l mRNAs. Total RNA samples extracted from different hematopoietic cells were fractionated by electrophoresis, transferred to nylon membranes, and hybridized with radiolabeled EpoR or GATA-1 cDNA probes (Fig 1) . Approximately equal amounts of RNA were loaded into each lane as judged by the intensity of staining of the ribosomal 28s and 18s bands HAGOP YOUSSOUFIAN (Fig 1) . The expression of EpoR in MEL cells was approximately fivefold higher than in CB-S cells, whereas GATA-1 mRNA levels in the two cell types was approximately equal. By contrast, both EpoR and GATA-l mRNA expression were very low in FDC-P1 cells. The coordinate expression of GATA-l and EpoR is consistent with the view that GATA-l is necessary for the activation of the EpoR and the very modest expression of EpoR in FDC-P1 cells may be the result of either suboptimal activation of the promoter by low levels of GATA-l or GATA-l-independent activation of transcription. However, the higher levels of EpoR mRNA in MEL versus CB-5 cells cannot be accounted for by a concomitant rise in the level of GATA-1.
Analysis o f the EpoR promoter region. To narrow the boundaries of the erythroid-specific promoter, smaller regions of the 450-bp promoter were subcloned into plasmid vectors containing the hGH gene and assayed for promoter activity.* Recombinant plasmids were electroporated into cells, and the conditioned media was assayed for hGH levels after 72 hours. To normalize for transfection efficiencies, pCH 1 10 was cotransfected with hGH-encoding plasmids, and transfected cells were assayed for @-galactosidase expression by histochemical staining (data not shown). Constructs 2 and 3 (Fig 2) showed approximately equal, relatively high levels of promoter activity in both MEL and CB-5 cells, but were inactive in COS-1 cells. Construct 4 was significantly weaker in both erythroid cells. These results narrow the boundaries of the erythroid-specific promoter to the region from -220 bp to -138 bp, and show that sequences upstream of the GATA-l-binding site between -386 bp and -220 bp contribute to the overall strength of the promoter. To examine for potential DNA binding activities, in vitro DNase I footprinting was performed over the region from -752 bp to -138 bp. Using a probe corresponding to the noncoding strand relative to the downstream gene, a strong footprint in the region from -269 bp to -254 bp corresponding to the proximal CACCC-binding site,32 and refer- 
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6. ences therein, was observed with nuclear extracts from both MEL and CB-5 cells (Fig 3) . In addition, a weak footprint was observed over the region from -523 bp to -5 17 bp in MEL cells. The footprint corresponding to the GATA-1 and Sp-l-binding sites are not shown on these autoradiograms. These results suggest that the proximal CACCC-binding site may influence the activity of the promoter. To test for this possibility, this site was mutated from the wild-type sequence 5"CACCC to 5'-GGGCC. This change completely obliterated the footprint observed with the wild-type sequence (data not shown). Significantly, promoter activity was less than half of the wild-type construct in erythroid cells (compare constructs 3 and 5, Fig 2) but remained inactive in COS-l cells. These results suggest that the proximal CACCC-binding site contributes to the overall strength of the promoter. DNase I hypersensitive sites in the locus of the murine EpoR gene. Because the CACCC-binding site contributes equally to promoter strength in both MEL and CB-5 cells, the chromatin organization of the EpoR genomic locus was analyzed in an effort to identify additional cis-acting sequences that could account for this difference. The DNase I hypersensitivity (DH) profile of this locus was determined using four probes that span the murine EpoR gene (Fig 4) . DNase I cleaves DH sites of nucleosomal DNA within a limited size range, not in a site-specific manner, creating nonidentical DNA termini. By contrast, a restriction enzyme cleaves DNA in a site-specific manner, which clearly delimits the size of the resulting fragment by generating identical termini. The action of DNase I on nucleosomal DNA followed by digestion with a restriction enzyme yields fragments that are reasonably homogeneous in size and are recognized as specific bands by Southern analysis. For example, cleavage of DNA with BamHI yields a 3.6-kb fragment with probe a (Fig 4) . Prior incubation of MEL nucleosomal DNA with DNase I yields at least three additional fragments of lower molarity (Fig 5) : a -0.5-kb fragment that corresponds to the distance from DH3 to DH2; a -1.6-kb fragment that corresponds to the distance from the 5' BamHI site to DH3; and a broader band in the size range of -2.1 to 3 kb that corresponds to fragments generated by the combination of the BamHI site in intron 3 and DH3 (-2.1 kb) or DH2 (-2.6 kb). Physical mapping with additional restriction enzymes (Fig 5) localized the DH sites to the 5' flanking region within approximately 100 to 200 bp on the previously established restriction map. DH3 maps to the region of the minimum promoter; DH2 maps downstream of a rodent-specific repetitive element; and DH 1 maps approximately 2.4 kb upstream of the EpoR transcriptional initiation sites (Fig 4) . Using PstI and probe a, a markedly different pattern of DH sites was observed for nucleosomal DNA of CB-5 and FDC-P1 cells (Fig 6) , which showed expression of DH3 exclusively (Fig 6) . Similarly, DH3 expression, but not DH1 or DH2, was also detected in the nucleosomal DNA of NIH3T3 and lymphoid Ba/F3 cells (data not shown). These observations show that DH3 is expressed constitutively in the nucleosomal DNA of a variety of murine cell lines, whereas DH1 and DH2 are expressed specifically in MEL cells. To identify other potential DH sites in this locus, the filters were stripped of probe a and hybridized successively with probes b, c, and d. No additional degradation bands were observed (data not shown). Thus, within this genomic locus of approximately 20 kb spanned by the combination of these probes and restriction enzymes, DH sites were observed only in the 5' flanking region of the murine EpoR gene.
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Identijication of an enhancer. To identify functions associated with the 5' flanking DNA sequences marked by DH 1 and DH2, restriction fragments spanning these sites were subcloned into plasmid vectors containing the hGH gene and assayed for promoter or enhancer activities. Because of the presence of the RRE that interferes with the activity of the EpoR promoter,13 the 5' flanking region from -1.7 kb to -0.24 kb was deleted (Fig 7) . Except for the EpoR promoter defined previously (Youssoufian et als and present study), subcloning of three upstream DNA fragments into pOGH and transfection into MEL cells yielded no additional promoters in the 5' flanking DNA from -4.7 kb to -0.24 kb (data not shown). For the demonstration of upstream enhancers, the 256-bp Nael-Pvull fragment that contains binding sites for Sp-I , GATA-l , and the proximal CACCC element (construct 3, Fig 2) was used as a parental construct to subclone additional fragments from the 5' flanking region of the EpoR gene upstream of the Nael site at -0.24 kb. A 3.0-kb KpnI-BarnHI fragment caused an approximately fourfold increase in transcription from the linked 256-bp fragment (compare construct 3, Fig 2 with   construct I, Fig 7) . The active segment was further localized to a 0.8-kb SmaI-BgIII fragment (Fig 7, construct 5 ). This fragment also enhanced transcription from the EpoR promoter when placed in the opposite orientation relative to the latter (construct 6, Fig 7) . At best, a 1 S-fold increase in transcription was detected in CB-5 cells, and no enhancer activity was detected in COS/G cells. These results show the presence of an enhancer upstream of the murine EpoR gene promoter, and suggest that the enhancer functions specifically in MEL cells. Finally, to assess the promoter specificity of this enhancer, the 0.8-kb SmaI-BgIII fragment was cloned upstream ofthe TK promoter in pTKGH. Despite a high baseline promoter activity of pTKGH, inclusion of the 0.8-kb EpoR fragment caused an approximately fourfold increase in MEL cells as assessed by hGH levels (compare constructs 7 and 8, Fig 7) . However, when assayed in COS-l cells, there was no increase in TK promoter activity irrespective of GATA-l coexpression (constructs 6 and 7, Fig  7) . Transfection of CB-5 cells with a construct containing the 1.2-kb SmaI-EcoRI fragment also failed to show the enhancer activity (constructs 7 and 8, Fig 7) . These results suggest that the enhancer can activate transcription from a linked heterologous promoter in MEL cells, but its function is not affected by the presence of GATA-l.
DISCUSSION
One ofthe most important developmental stages of mammalian erythroid progenitor cells is marked by their acquisition of Epo ~ensitivity.~" The molecular mechanism that mediates this physiologic switch is obscure, although in principle it may result from changes in the level or binding properties of the EpoR or in the activation of molecules involved in signal transduction. The regulation of these molecules may, in turn, be controlled by transcriptional or posttranscriptional mechanisms. Differences in the metabolism or translocation of the EpoR protein may also influence the enhanced surface expression of the EpoR during erythroid differentiation. '7,33 In this study, the transcriptional activity ofthe EpoR gene was evaluated in murine cell lines that represent distinct stages of hematopoiesis. With some caution, CB-5 cells (BFUe-like)" and MEL cells (CFUe-like)" can be important tools for analyzing molecular events that occur during the BFUe and CFUe stages. Previously, the transcription factor GATA-1 was shown to be necessary for the function of the murine EpoR promoter linked to a reporter gene.".'* In addition, the activity of the EpoR promoter was not significantly different in MEL and CB-5 cells (Youssoufian and LodishI3 and present study). Preliminary actinomycin chase assays showed no differences in the half-life of EpoR mRNA ("3.5 hours) derived from MEL or CB-5 cells, and primer extension studies showed approximately equivalent locations of transcriptional start sites (Youssoufian H, personal observations). Thus, the fivefold difference in the steadystate level of EpoR mRNA is believed to result from a higher level of transcription in MEL cells. Most of the difference in the rate of EpoR gene transcription between MEL and CB-5 cells can be accounted for by the contribution of the upstream enhancer. Taken together, these data show ( I ) an 83-bp fragment that functions as an erythroid-specific promoter; ( 2 ) a CACCC-binding site that contributes to the strength of the promoter in both MEL and CB-5 cells, but is not essential for promoter activity; and (3) an upstream enhancer that contributes to promoter activity primarily in MEL cells. Although the proximal CACCC-binding site is not a perfect consensus for the binding site of a recently identified transcription factor, it may bind to this factor or to other members of this far nil^.^' Two of three DH sites detected in the locus of the murine EpoR gene were expressed exclusively in MEL cells. Recently, Heberlein et a134 delineated at least nine DH sites in the locus of the murine EpoR gene, both in the 5' flanking region and within intron 1, and a fragment spanning an intron 1 site functioned as an enhancer. Unlike the present study, no stage-specific differences were observed in the expression of any of these sites. The intron l-associated site34 was not detected in the present study. The reason for these differences is not yet apparent. Presumably some of the differences in DH site expression are not functionally important and may be expected to show variation among different erythroid cell lines or sublines as neutral polymorphisms. To resolve these issues, additional cell culture systems, especially purified erythroid progenitor cells, need to be examined.
These data are consistent with the expression of a stagespecific enhancer in the vicinity of DH 1. This region has not yet been sequenced completely and potential binding sites for known transcription factors are not yet identified. The disparity in function of the enhancer between MEL versus CB-5 and COS-l cells suggests that the cognate protein is present in MEL, but it may be absent in CB-5 cells or it may be present at low levels. Alternatively, it may be expressed constitutively, but its activity may be regulated by factors present in MEL cells. Coexpression of GATA-I in COS-l cells shows that this enhancer-binding site is not regulated by GATA-1. Insofar as MEL and CB-5 cells represent distinct stages of erythroid cell differentiation, it is tempting to speculate that the expression of an active enhancer is affected during BFUe to CFUe transition.
As hallmarks of "open" chromatin, DH sites are thought to make neighboring genes and promoter elements more accessible to transcription factors.35 These sites often span promoter or enhancer sequences in actively transcribed genes. It is noteworthy that the region demarcated by the constitutively expressed DH3 corresponds to the EpoR promoter.
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